Neogen Chemicals Ltd

Neogen Chemicals Ltd

₹ 1,883 -0.96%
04 Jun - close price
About

Neogen Chemicals Ltd, incorporated in 1991, manufactures bromine and lithium-based organic and organo-metallic compounds, used in the pharmaceutical, agricultural chemicals, and engineering industries. [1]

Key Points

About
The company manufactures Bromine and Lithium-based chemical compounds.It also manufactures advanced intermediates in Pharma / Agro / Flavours and Fragrances. [1] Neogen is the largest importer of Lithium Carbonate & Lithium Hydroxide for last 3 decades.[2]

  • Market Cap 5,154 Cr.
  • Current Price 1,883
  • High / Low 1,960 / 967
  • Stock P/E 179
  • Book Value 309
  • Dividend Yield 0.05 %
  • ROCE 6.46 %
  • ROE 3.58 %
  • Face Value 10.0

Pros

  • Promoter holding has increased by 1.78% over last quarter.
  • Company's median sales growth is 20.3% of last 10 years
  • Company's working capital requirements have reduced from 112 days to 84.6 days

Cons

  • Stock is trading at 6.09 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 4.90% over last 3 years.
  • Company might be capitalizing the interest cost
  • Dividend payout has been low at 7.46% of profits over last 3 years
  • Company has high debtors of 161 days.
  • Promoter holding has decreased over last 3 years: -7.18%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
204 165 162 164 200 180 193 201 203 187 209 220 247
171 137 136 144 164 149 159 167 166 155 179 188 203
Operating Profit 33 28 26 20 36 31 35 35 36 32 30 32 44
OPM % 16% 17% 16% 12% 18% 17% 18% 17% 18% 17% 14% 14% 18%
2 2 2 2 2 2 1 1 -13 1 2 2 1
Interest 9 11 11 11 10 10 13 13 12 13 19 22 21
Depreciation 4 5 6 6 6 7 7 7 7 6 7 7 8
Profit before tax 21 14 11 6 22 16 15 15 4 14 5 6 16
Tax % 31% 28% 28% 81% 25% 27% 29% 34% 35% 28% 35% 36% 28%
14 10 8 1 17 11 11 10 2 10 3 4 11
EPS in Rs 5.74 3.91 3.18 0.40 6.42 4.35 4.15 3.79 0.91 3.89 1.28 1.40 4.32
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
84 100 110 161 239 306 336 487 686 691 778 862
71 86 90 132 196 248 272 401 575 581 641 725
Operating Profit 13 14 20 29 43 58 64 87 112 110 136 137
OPM % 15% 14% 18% 18% 18% 19% 19% 18% 16% 16% 18% 16%
1 0 0 1 1 0 1 1 5 8 -10 6
Interest 5 5 8 10 12 12 14 19 29 42 48 75
Depreciation 1 1 1 2 3 5 7 12 16 23 28 28
Profit before tax 8 8 12 17 29 41 44 57 71 53 50 41
Tax % 37% 39% 33% 37% 28% 30% 29% 22% 30% 32% 31% 30%
5 5 8 11 21 29 31 45 50 36 35 29
EPS in Rs 11.31 2.59 3.84 5.49 10.43 12.28 13.43 17.90 20.04 13.51 13.20 10.90
Dividend Payout % 18% 17% 0% 18% 14% 16% 17% 15% 15% 15% 8% 0%
Compounded Sales Growth
10 Years: 24%
5 Years: 21%
3 Years: 8%
TTM: 11%
Compounded Profit Growth
10 Years: 19%
5 Years: -2%
3 Years: -17%
TTM: -34%
Stock Price CAGR
10 Years: %
5 Years: 16%
3 Years: 6%
1 Year: 12%
Return on Equity
10 Years: 9%
5 Years: 7%
3 Years: 5%
Last Year: 4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 4 20 20 20 20 23 23 25 25 26 26 26
Reserves 19 8 22 30 50 133 160 414 458 734 763 790
24 26 69 82 120 137 222 229 370 409 597 1,395
21 26 41 48 56 61 87 131 202 292 361 691
Total Liabilities 69 80 152 180 246 355 492 799 1,054 1,461 1,747 2,902
13 17 56 67 83 111 127 285 347 496 404 475
CWIP 0 1 1 1 0 3 115 11 36 109 156 857
Investments 0 0 0 0 1 1 1 82 77 0 0 0
55 62 94 112 163 241 250 422 594 856 1,187 1,570
Total Assets 69 80 152 180 246 355 492 799 1,054 1,461 1,747 2,902

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
9 9 0 12 -4 -35 84 1 -30 -29 196 -231
-2 -4 -33 -13 -20 -29 -135 -146 -94 -216 -317 -410
-6 -4 33 -0 24 63 51 188 100 237 113 642
Net Cash Flow 1 0 1 -1 0 -1 -0 44 -25 -8 -8 -0
Free Cash Flow 7 4 -33 -1 -24 -63 -51 -65 -134 -332 -121 -647
CFO/OP 89% 83% 21% 55% 4% -38% 146% 13% -17% -18% 153% -154%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 78 58 107 94 93 90 85 82 94 149 94 161
Inventory Days 178 190 228 192 188 257 211 258 275 365 267 445
Days Payable 120 130 177 141 111 71 122 131 147 138 227 346
Cash Conversion Cycle 136 117 158 145 169 276 174 209 223 376 134 260
Working Capital Days 140 126 174 48 63 95 66 111 79 129 123 85
ROCE % 27% 26% 23% 23% 26% 22% 17% 14% 13% 9% 9% 6%

Insights

In beta
Mar 2012 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2027 (P)
Organic Chemicals Total Reactor Capacity
m3

Log in to view insights

Please log in to see hidden values.

Login
Inorganic Chemicals Total Capacity
MTPA
Export Footprint
Countries
Total Number of Products Developed
Number
Mahape Facility Organic Capacity Utilization
% ・Standalone data
Electrolyte Solutions Capacity
MT/Annum
Vadodara Facility Organic Capacity Utilization
% ・Standalone data
Lithium Electrolyte Salt Capacity
MT/Annum

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Apr 2026
60.18% 56.89% 56.89% 56.89% 51.22% 51.22% 51.22% 51.22% 51.22% 51.22% 51.22% 53.00%
4.25% 4.51% 4.56% 4.65% 8.17% 7.73% 7.79% 7.35% 5.15% 4.57% 4.46% 4.29%
20.25% 22.85% 22.14% 22.54% 22.48% 22.52% 22.75% 22.96% 25.22% 21.99% 22.65% 21.67%
15.32% 15.75% 16.42% 15.93% 18.12% 18.51% 18.22% 18.45% 18.40% 22.21% 21.67% 21.05%
No. of Shareholders 45,30047,01848,35646,69846,47047,65146,10446,32145,71047,88454,33256,330

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls